Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence

Yu-Ming Wang (Inventor)

Research output: Patent

Abstract

The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.
Original languageEnglish
Patent number9610325
Publication statusPublished - 2015 Jan 22

Fingerprint

Amino Acid Sequence
Phagocytosis
Macrophages
Nasopharyngeal carcinoma

Cite this

@misc{6b6d5a87a6aa41beae39162b2856c55d,
title = "Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence",
abstract = "The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.",
author = "Yu-Ming Wang",
year = "2015",
month = "1",
day = "22",
language = "English",
type = "Patent",
note = "9610325",

}

TY - PAT

T1 - Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence

AU - Wang, Yu-Ming

PY - 2015/1/22

Y1 - 2015/1/22

N2 - The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.

AB - The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.

M3 - Patent

M1 - 9610325

ER -